130 related articles for article (PubMed ID: 2455679)
1. Immunohistochemical and immunoelectron microscopic study of an amylase-producing, CA19-9 positive ovarian mucinous cystadenocarcinoma.
Teshima H; Kitamura H; Mizoguchi Y; Hino S; Mizutani K; Mori H; Kigawa T
Gynecol Oncol; 1988 Jul; 30(3):372-80. PubMed ID: 2455679
[TBL] [Abstract][Full Text] [Related]
2. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
3. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
4. An amylase-producing serous cystadenocarcinoma of the ovary.
Hodes ME; Sisk CJ; Karn RC; Ehrlich CE; Lehrner LM; Roth LM; Morley DJ; Merritt AD
Oncology; 1985; 42(4):242-7. PubMed ID: 2409494
[TBL] [Abstract][Full Text] [Related]
5. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein.
Konishi I; Fujii S; Kataoka N; Noda Y; Okamura H; Yamabe H; Mori T
Int J Gynecol Pathol; 1988; 7(2):182-9. PubMed ID: 2456275
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and ultrastructural localization of T antigen in ovarian tumors.
Ghazizadeh M; Oguro T; Sasaki Y; Aihara K; Araki T; Springer GF
Am J Clin Pathol; 1990 Mar; 93(3):315-21. PubMed ID: 1689937
[TBL] [Abstract][Full Text] [Related]
7. Ovarian tumor antigens: preliminary histological investigation.
Daunter B; Jaa-Kwee D; Miklosi S; Wright G
Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
[TBL] [Abstract][Full Text] [Related]
8. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
9. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia].
Nakamura S; Hirabayashi N; Asai J
Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
11. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological studies on amylase-producing ovarian cancer].
Matsuda M; Izutsu T; Kagabu T; Nishiya I; Iida H; Kubota T
Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):935-42. PubMed ID: 2414384
[No Abstract] [Full Text] [Related]
13. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
Tohya T; Iwamasa T; Maeyama M
Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
[TBL] [Abstract][Full Text] [Related]
14. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
Kato T; Nishimura H; Hamai J; Yamabe T; Nakajima H; Nakano T; Noda K; Teshima K; Suzuki H; Ueda G
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2338-45. PubMed ID: 3007640
[No Abstract] [Full Text] [Related]
16. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
[TBL] [Abstract][Full Text] [Related]
17. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
18. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
19. [A case of amylase-producing ovarian tumor].
Tanaka Y; Ueda G; Tanizawa O; Miyake H; Kohno M; Nishiyama S; Inoue H; Ikeuchi H; Sekigawa S; Matsunaga S
Gan No Rinsho; 1986 Jan; 32(1):111-6. PubMed ID: 2419596
[TBL] [Abstract][Full Text] [Related]
20. [Value of SLX and CA19-9 in the serum and tissue in colorectal cancer including the relation to Lewis blood type].
Igarashi K
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2394-403. PubMed ID: 2574243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]